EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Utilization of the Nortropinone Scaffold in the Structure-Guided Design of Potent Inhibitors of Human Cathepsin L and the Chymotrypsin-like Proteases of SARS-CoV-2 and MERS-CoV

Pulini S. Ranasinghe, I. Kankanamge Ravindu S. Ilesinghe, Chamandi S. Dampalla, Harry Nhat Nguyen, Zeeshan Azmi, Zoie Liska, John X. Bourget, Dennis J. Howard, Dustin E. Nevonen, Yunjeong Kim, Kevin P. Battaile, Anne Cooper, Adron R. Ung, Hayden A. Thurman, Egor Gusachenko, David K. Johnson, Scott Lovell, Kyeong-Ok Chang, William C. Groutas

ACS Pharmacology & Translational Science · 2026-11-07

DOI: 10.1021/acsptsci.6c00439 ↗
AbstractBibliografische Angaben

Abstract

Abstract Coronaviruses, including SARS-CoV-2 and MERS-CoV, encode two large polyproteins, pp1a and pp1ab, that are primarily processed by highly conserved 3C-like proteases, yielding an array of structural and nonstructural proteins essential for viral replication. SARS-CoV-2 3CLpro is deemed to be a well-established and validated antiviral target. During cell entry, pathogenic coronaviruses, particularly the SARS-CoV-2 Omicron variants, utilize host cell cathepsins, including cathepsin L (CatL), and the endosomal pathway for successful infection. Furthermore, SARS-CoV-2 infection results in overexpression of CatL, which, in turn, intensifies SARS-CoV-2 infection. Consequently, CatL has emerged as a potential target for the development of COVID-19 therapeutics. We report herein a series of inhibitors that incorporate in their structure a nortropinone scaffold as a design element for probing and exploiting poorly explored regions of chemical space. The inhibitors were found to be noncytotoxic and to potently inhibit CatL and the 3CLpro of MERS-CoV and SARS-CoV-2. The IC50 values of compound 12 against human CatL, MERS-CoV 3CLpro, and SARS-CoV-2 3CLpro were determined to be 0.12 nM, 0.11 μM, and 0.38 μM, respectively. Furthermore, compound 12 was found to inhibit SARS-CoV-2 infection in vitro with an EC50 value of 0.09 ± 0.05 μM and a Safety Index >1100. High-resolution cocrystal structures with SARS-CoV-2 3CLpro and MERS-CoV 3CLpro confirmed the mechanism of action of the compounds, illuminated the molecular determinants associated with binding, and informed the optimization of the inhibitors.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →